<DOC>
	<DOCNO>NCT01918592</DOCNO>
	<brief_summary>Muscle invasive bladder cancer aggressive malignancy . Currently investigators lack accurate imaging technology clinical stag estimation response neoadjuvant chemotherapy well prognostic biomarkers . In current study novel image modality ( MRI/PET ) utilize stage bladder cancer prior transurethral resection bladder-tumor neoadjuvant chemotherapy . Also prognostic biomarkers study TUR-BT tissue , blood urine estimate response neoadjuvant chemotherapy .</brief_summary>
	<brief_title>PET/MRI Biomarkers Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>invasive locally advanced bladder cancer base cystoscopic evaluation Age : 18 85 year old Language spoken : Finnish Swedish Mental status : Patients must able understand meaning study Informed consent : The patient must sign appropriate Ethical Committee ( EC ) approve informed consent document presence designate staff Prior medical history : Patient must history serious cardiovascular , liver kidney disease Infections : Patient must uncontrolled serious infection Contraindications MRI ( cardiac pacemaker , intracranial clip etc ) Patient refuse radical cystectomy chemotherapy Intravesical Bacillus CalmetteGuerin instillation within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>bladder cancer</keyword>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>radical cystectomy</keyword>
	<keyword>lymphadenectomy</keyword>
	<keyword>biomarker</keyword>
</DOC>